🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TCR lovers, we are delighted to share our benchmarking of TCR specificity tools using an harmonized aggregation of public databases. biorxiv.org/content/10.110…

UF Health and Universitetet i Oslo investigators analyzed #AIRRseq data from 2250 individuals using machine learning (ML) approaches, identifying T cell receptor motif-based biomarkers of #T1D. Click here to read more medrxiv.org/content/10.110… Helmsley Charitable Trust NIAID News Puneet Rawat, PhD

Extremely pleased to share our new work in collaboration with the Todd M. Brusko lab where we leveraged one of the largest TCRbeta sequencing datasets to identify T1D-associated TCR-based signatures. Paper link and 🧵 are below. Incredible work led by Puneet Rawat, PhD.

Our new review on AI/ML applications toward #T1D immunotherapy is out in Diabetologia about drug repurposing, precision medicine & more! Thanks to collaborators: Matthew Brown Todd M. Brusko Mark Clements, M.D., Ph.D. Children's Mercy Research Institute, funders: Breakthrough T1D NIDDK Helmsley Charitable Trust

YAbS: The Antibody Society's antibody therapeutics database biorxiv.org/content/10.110… #biorxiv_scicomm

YAbS: The Antibody Society’s Antibody Therapeutics Database 1/ YAbS provides an extensive and dynamic resource tracking over 2,900 antibody therapeutics, including approved, investigational, and in-development antibody candidates, offering a valuable tool for researchers,

🚨Looking for a job in immunology and biotech research? IMPRINT is #hiring! Join us to help revolutionize how we decode the body’s immune memory, uncover the causes of chronic diseases, and drive breakthroughs in autoimmunity and neuropsychiatric research. IMPRINT is seeking